Related Experiment Video
Updated: Aug 14, 2026
11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Heparin-induced thrombocytopenia and thrombosis
1The Blood Research Institute, Blood Center of Southeastern Wisconsin, Milwaukee, WI 53201-2178, USA.
American Journal of Hematology
|December 22, 2005
Summary
Heparin is a common anticoagulant, but it can cause dangerous thrombocytopenia and thrombosis in some patients. Understanding its causes, diagnosis, and treatment is crucial for clinicians.
Area of Science:
- Pharmacology
- Hematology
- Clinical Medicine
Background:
- Heparin has been a cornerstone anticoagulant for over 50 years.
- A significant subset of patients receiving heparin develop heparin-induced thrombocytopenia (HIT) and thrombosis.
- This adverse event carries severe clinical consequences.
Purpose of the Study:
- To underscore the importance of understanding heparin's adverse effects.
- To emphasize the need for basic knowledge of HIT pathogenesis, diagnosis, and management among clinicians.
Main Methods:
- Review of existing literature on heparin pharmacology and adverse reactions.
- Analysis of clinical case reports and epidemiological data related to heparin-induced complications.
- Synthesis of current diagnostic criteria and management strategies for HIT.
Main Results:
- Heparin-induced thrombocytopenia (HIT) is a serious immune-mediated complication.
- Thrombosis is a frequent and severe consequence of HIT.
- Early recognition and appropriate management are critical to patient outcomes.
Conclusions:
- Clinicians must be aware of the risks associated with heparin therapy.
- A fundamental understanding of HIT pathogenesis, diagnosis, and management is essential for all healthcare providers.
- Proactive management can mitigate the catastrophic consequences of heparin-induced thrombosis.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...